Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating myocardial ischemia

A technology of myocardial ischemia and composition, which is applied in the directions of drug combination, cardiovascular system diseases, pharmaceutical formulations, etc., can solve the problems such as the ineffective efficacy of drugs for myocardial ischemia treatment.

Inactive Publication Date: 2016-03-16
杨文灿
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The present invention aims at the technical defects of the prior art, and provides a pharmaceutical composition for the treatment of myocardial ischemia, so as to solve the technical problem in the prior art that the curative effect of the drug for the treatment of myocardial ischemia is not obvious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating myocardial ischemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A medicinal composition for treating myocardial ischemia, which is composed of the following ingredients in parts by weight: 8 parts of Herba blood, 4 parts of Poria cocos, 2 parts of coix seed, 1 part of plantain, 1 part of dandelion, 1 part of tortoise flower, 1 part of Sedum notoginseng, 1 part of Fotan mother, 1 part of abacus, and 1 part of Imperata rhizome.

Embodiment 2

[0030] A pharmaceutical composition for treating myocardial ischemia, which is composed of the following ingredients in parts by weight: 10 parts of Rhizoma japonica, 6 parts of Poria cocos, 3 parts of coix seed, 2 parts of plantain, 2 parts of dandelion, 2 parts of tortoise flower, 2 parts of Sedum notoginseng, 2 parts of Fotan mother, 2 parts of abacus, and 2 parts of Imperata rhizome.

Embodiment 3

[0032] A pharmaceutical composition for treating myocardial ischemia, which consists of the following ingredients in parts by weight: 9 parts of Herbs, 5 parts of Poria cocos, 2.3 parts of coix seed, 1.8 parts of plantain, 1.5 parts of dandelion, 1.6 parts of tortoise flower, 1.7 parts of Sedum notoginseng, 1.8 parts of Fotan mother, 1.2 parts of abacus, and 1.8 parts of Imperata rhizome.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicinal composition for treating myocardial ischemia. Rhizoma polygoni paleacei and poria cocos are taken as the main components and simultaneously matched with the components of semen coicis, plantain herb, dandelion, bitter citrus immature flowers, alpine stonecrop, polygonum chinense, puberulous glochidion herb and lalang grass rhizomes to prepare the composition. Although all the components generally do not have the direct promoting action on treatment of cardiovascular system or myocardial ischemia separately according to the existing medical cognitive level, it is accidentally discovered through an experimental means that the medicinal composition obtained by integrating all the components and optimizing and designing the using amount of all the components can effectively treat the myocardial ischemia, the effects are achieved quickly, and no adverse reaction exists. On the basis of the positive discovery, the medicinal composition is obtained, and the outstanding technical effect of the composition is achieved through ingenious material selection and the reasonable using amount; meanwhile, the cost is lower, implementation is easy, and the outstanding popularization prospect is achieved.

Description

technical field [0001] The invention relates to the technical field of cardiovascular disease treatment, in particular to a pharmaceutical composition for treating myocardial ischemia. Background technique [0002] Myocardial ischemia refers to a pathological state in which the blood perfusion of the heart is reduced, resulting in reduced oxygen supply to the heart, abnormal myocardial energy metabolism, and failure to support the normal work of the heart. Coronary heart disease is the most important and common cause of myocardial ischemia. With the improvement of people's living standards, the prevalence of myocardial ischemia in my country is increasing year by year. Myocardial ischemia is a common and frequently-occurring disease in middle-aged and elderly people. [0003] Since myocardial ischemia has the risk of myocardial infarction and sudden death, when myocardial ischemia is found, it should be treated as soon as possible. Actively prevent the occurrence of ather...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8994A61P9/10
CPCA61K36/8994A61K36/074A61K36/076A61K36/288A61K36/355A61K36/41A61K36/47A61K36/634A61K36/68A61K36/704A61K36/752A61K36/8968A61K36/899
Inventor 杨文灿
Owner 杨文灿
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products